Corneal
Refractive Surgery/Retina/
Advanced Glaucoma Treatments
Nearly 70% of respondents use UCVA of 20/20
or better to assess their LVC outcomes. 11%
do not have a standardized way of assessing
outcomes. However, this has dropped 9% since
the 2015 ASCRS Clinical Survey.
More than 35% of respondents to the ASCRS
Clinical Survey perform intravitreal injections,
and 80% have confidence in the timing of retinal
disease therapies with respect to cataract
surgery.
Overall, respondents report seeing roughly
50 patients per month with glaucoma, and
13% of all cataract patients are estimated
to have glaucoma. Additionally, 70% of
respondents do not currently use MIGS.
However, an average of 20% of patients
with glaucoma are estimated to be
candidates for a MIGS device.
Overall, respondents to the 2016 ASCRS Clinical
Survey think that 32% of their patients who are
prescribed one medication are not compliant.
This increases to 37% for two medications and
43% for more than two medications.
ASCRS 2016 Clinical Survey
8
